Authors:
BLACHER J
RAISON J
AMAH G
SCHIEMANN AL
STIMPEL M
SAFAR ME
Citation: J. Blacher et al., INCREASED ARTERIAL DISTENSIBILITY IN POSTMENOPAUSAL HYPERTENSIVE WOMEN WITH AND WITHOUT HORMONE REPLACEMENT THERAPY AFTER ACUTE ADMINISTRATION OF THE ACE-INHIBITOR MOEXIPRIL, Cardiovascular drugs and therapy, 12(4), 1998, pp. 409-414
Citation: M. Stimpel et al., COMPARISON BETWEEN MOEXIPRIL AND ATENOLOL IN OBESE POSTMENOPAUSAL WOMEN WITH HYPERTENSION, Maturitas, 30(1), 1998, pp. 69-77
Authors:
GROHE C
KAHLERT S
LOBBERT K
NEYSES L
VANEICKELS M
STIMPEL M
VETTER H
Citation: C. Grohe et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION MODULATES CARDIAC FIBROBLASTGROWTH, Journal of hypertension, 16(3), 1998, pp. 377-384
Citation: Sg. Chrysant et M. Stimpel, ANTIHYPERTENSIVE EFFECTIVENESS OF A VERY-LOW FIXED-DOSE COMBINATION OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE, Journal of cardiovascular pharmacology, 31(3), 1998, pp. 384-390
Citation: M. Stimpel et al., ANTIHYPERTENSIVE TREATMENT IN POSTMENOPAUSAL WOMEN - RESULTS FROM A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY COMPARING AN ACE-INHIBITOR (MOEXIPRIL) WITH A DIURETIC (HYDROCHLOROTHIAZIDE), Cardiology, 89(4), 1998, pp. 271-276
Citation: M. Stimpel et B. Koch, ANTIHYPERTENSIVE TREATMENT WITH MOEXIPRIL PLUS HCTZ VS METOPROLOL PLUS HCTZ IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of human hypertension, 11(2), 1997, pp. 133-137
Citation: M. Stimpel et B. Koch, SAFETY AND EFFICACY OF MOEXIPRIL AND ATENOLOL IN POSTMENOPAUSAL WOMENWITH HYPERTENSION, Hypertension, 29(3), 1997, pp. 23-23
Citation: M. Stimpel et B. Koch, MOEXIPRIL IS BETTER TOLERATED THAN HYDROCHLOROTHIAZIDE IN POSTMENOPAUSAL WOMEN WITH HYPERTENSION, Hypertension, 29(3), 1997, pp. 25-25
Citation: Di. Prusse et M. Stimpel, BLOOD-PRESSURE RESPONSE AND SAFETY PROFILE OF MOEXIPRIL AND NITRENDIPINE IN POSTMENOPAUSAL, HYPERTENSIVE WOMEN, Hypertension, 29(3), 1997, pp. 26-26
Citation: M. Stimpel et al., ANGIOTENSIN-II IS GENERATED FROM ANGIOTENSIN-I BY BONE-CELLS AND STIMULATES OSTEOCLASTIC BONE-RESORPTION IN-VITRO - IMPLICATIONS FOR ACE-INHIBITOR THERAPY UNDER CONDITIONS OF PROGRESSIVE BONE LOSS, Hypertension, 29(3), 1997, pp. 41-41
Citation: B. Koch et M. Stimpel, LOW-DOSE COMBINATION OF MOEXIPRIL AND HCTZ - AN OPTION IN ANTIHYPERTENSIVE TREATMENT, Hypertension, 29(3), 1997, pp. 117-117
Citation: Yf. Ma et al., IMPACT OF ANTIHYPERTENSIVE THERAPY ON THE SKELETON - EFFECTS OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE ON OSTEOPENIA IN SPONTANEOUSLY HYPERTENSIVE OVARIECTOMIZED RATS, Journal of Endocrinology, 154(3), 1997, pp. 467-474
Citation: R. Hatton et al., ANGIOTENSIN-II IS GENERATED FROM ANGIOTENSIN-I BY BONE-CELLS AND STIMULATES OSTEOCLASTIC BONE-RESORPTION IN-VITRO, Journal of Endocrinology, 152(1), 1997, pp. 5-10
Authors:
GROHE C
KAHLERT S
LOBBERT K
VANEICKELS M
STIMPEL M
VETTER H
NEYSES L
Citation: C. Grohe et al., EFFECTS OF MOEXIPRILAT ON ESTROGEN-STIMULATED CARDIAC FIBROBLAST GROWTH, British Journal of Pharmacology, 121(7), 1997, pp. 1350-1354
Citation: Hh. Liang et al., AGING-RELATED AND OVARIECTOMY-RELATED SKELETAL CHANGES IN SPONTANEOUSLY HYPERTENSIVE RATS, The Anatomical record, 249(2), 1997, pp. 173-180
Citation: R. Hatton et al., ANGIOTENSIN-II IS GENERATED FROM ANGIOTENSIN-I BY BONE-CELLS AND STIMULATES OSTEOCLASTIC BONE-RESORPTION IN-VITRO, Journal of bone and mineral research, 11, 1996, pp. 383-383
Citation: Wj. Mroczek et M. Stimpel, A DOUBLE-BLIND EVALUATION OF MOEXIPRIL VERSUS HYDROCHLOROTHIAZIDE IN HYPERTENSION, Advances in therapy, 13(2), 1996, pp. 79-87
Citation: M. Stimpel et al., MOEXIPRIL VERSUS CAPTOPRIL IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Journal of cardiovascular pharmacology, 28(6), 1996, pp. 769-773
Citation: Sg. Chrysant et M. Stimpel, A COMPARISON OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF A COMBINATION OF MOEXIPRIL OR SUSTAINED-RELEASE VERAPAMIL WITH LOW-DOSE HYDROCHLOROTHIAZIDE, Journal of clinical pharmacology, 36(8), 1996, pp. 701-706
Citation: B. Persson et M. Stimpel, EVALUATION OF THE ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OF MOEXIPRIL, A NEW ACE-INHIBITOR, COMPARED TO HYDROCHLOROTHIAZIDE IN ELDERLY PATIENTS, European Journal of Clinical Pharmacology, 50(4), 1996, pp. 259-264
Citation: M. Stimpel et al., MOEXIPRIL AS ADD-ON THERAPY TO HYDROCHLOROTHIAZIDE IN MODERATE TO SEVERE HYPERTENSION, Cardiology, 87(4), 1996, pp. 313-318
Citation: Wb. White et M. Stimpel, LONG-TERM SAFETY AND EFFICACY OF MOEXIPRIL ALONE AND IN COMBINATION WITH HYDROCHLOROTHIAZIDE IN ELDERLY PATIENTS WITH HYPERTENSION, Journal of human hypertension, 9(11), 1995, pp. 879-884